Verve Therapeutics Inc Shares Close the Day 11.9% Lower - Daily Wrap
The company saw its shares close the day 11.9% lower than yesterday, with trading volume higher than its 30 day average.
Sep 16, 2022 by Kwhen Finance Editors
Verve Therapeutics Inc (VERV) shares closed today 11.9% lower than it did at the end of yesterday. The stock is currently down 0.9% year-to-date, down 47.7% over the past 12 months, and up 14.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%.
Trading Activity
- Shares traded as high as $41.96 and as low as $34.25 this week.
- Shares closed 38.9% below its 52-week high and 241.6% above its 52-week low.
- Trading volume this week was 25.3% lower than the 10-day average and 15.8% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 2.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 6.5% lower than its 5-day moving average, 4.2% lower than its 20-day moving average, and 49.7% higher than its 90-day moving average.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Verve Therapeutics Inc | -11.9 | -0.9 | -47.7 | -33.4 | 272.1 |
| Dow Jones Industrial Average | -0.5 | -13.6 | -9.4 | -16.2 | 3.5 |
| S&P 500 Index | -0.8 | -17.3 | -11.7 | -19.4 | 6.1 |
| Technology Industry | 1.5 | 58.3 | 8.0 | -21.0 | 69.9 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -96.5%
- The company's stock price performance over the past 12 months lags the peer average by 113.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | VERV | 0 | -0.9 | -47.7 | -33.4 | 272.1 |
| Peer Avg | N/A | 0 | -24.6 | -22.3 | -27.9 | 28.1 |
| Oyster Point Pharma Inc | OYST | 0 | -63.1 | -49.5 | -68.4 | 82.7 |
| Ovid Therapeutics Inc | OVID | 0 | -35.2 | -39.7 | -43.4 | 29.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: